Shard Speciality Pharma Limited in Reading, RG7 4AB

Description

Data updated on: 01-11-2023

This enterprise is widely known under the name of Shard Speciality Pharma Limited. It was established 10 years ago and was registered with 09014679 as the reg. no. The office of this firm is situated in Reading. You can reach it at Merlin House Brunel Road, Theale. This firm's registered with SIC code 46460, that means Wholesale of pharmaceutical goods. The company's most recent annual accounts were submitted for the period up to Sat, 30th Apr 2022 and the latest confirmation statement was released on Fri, 28th Apr 2023.

At the moment, there’s a single managing director in the company: Michael C. (since 2014-04-28). This firm had been supervised by Paul R. until 2018-01-29. Furthermore a different director, specifically Parveen O. quit in 2017.

Michael C. is the individual who has control over this firm, has substantial control or influence over the company.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2015-04-30	2016-04-30	2017-04-30	2018-04-30	2019-04-30	2020-04-30	2021-04-30	2022-04-30	2023-04-30
Currency
Net Worth	5 000	63 082	34 982

Balance Sheet
Cash Bank On Hand			3 885	69 818	18 228	3 442	7 630	5 004	3 663
Current Assets	5 000	623 785	1 252 485	1 374 341	190 335	12 365	327 736	6 146	163 881
Debtors	5 000		270 389	1 136 189	4 655	1 974		1 142	19 305
Net Assets Liabilities			34 982	-1 107 039	-1 200 611
Other Debtors			180	4 063	4 610	1 930		1 142
Total Inventories			971 184	168 334	167 452	6 949	320 106
Cash Bank In Hand	5 000	1 500
Intangible Fixed Assets		553 506
Net Assets Liabilities Including Pension Asset Liability	5 000	63 082	34 982
Stocks Inventory		622 285

Capital & Reserves
Called Up Share Capital	5 000	5 000
Profit Loss Account Reserve		58 082
Shareholder Funds	5 000	63 082	34 982

Other Financial Data
Accumulated Amortisation Impairment Intangible Assets			276 753	415 129	553 505	691 881	691 881	691 881
Amounts Owed By Related Parties									19 305
Creditors			565 746	580 246	1 529 323	1 219 073	1 471 384	2 049 634	1 744 451
Dividends Paid On Shares				276 753	138 377
Increase From Amortisation Charge For Year Intangible Assets				138 376	138 376	138 376
Intangible Assets			415 129	276 753	138 377	1	1	1	1
Intangible Assets Gross Cost			691 882		691 882	691 882	691 882	691 882
Net Current Assets Liabilities	5 000	503 477	850 288	-803 546	-1 338 988	-1 206 708	-1 143 648	-2 043 488	-1 580 570
Nominal Value Allotted Share Capital				5 000	5 000	5 000	5 000	5 000	5 000
Number Shares Allotted	5 000					5 000	5 000
Number Shares Issued Fully Paid				5 000	5 000	5 000		5 000	5 000
Other Creditors			565 746	580 246	1 271 712	1 180 407	1 199 546	1 814 651	1 726 034
Other Taxation Social Security Payable			94 259			38 615	25 341		12 755
Par Value Share	1			1	1
Total Assets Less Current Liabilities	5 000	1 056 983	1 265 418	-526 793	-1 200 611	-1 206 707	-1 143 647	-2 043 487	-1 580 569
Trade Creditors Trade Payables			303 017	1 350 609	257 611	51	246 497	234 983	5 662
Trade Debtors Trade Receivables			270 209	1 132 126	45	44
Accruals Deferred Income		5 321	26 423
Creditors Due After One Year		993 901	1 204 013
Creditors Due Within One Year		114 987	402 197
Fixed Assets		553 506	415 130
Intangible Fixed Assets Additions		691 882
Intangible Fixed Assets Aggregate Amortisation Impairment		138 376
Intangible Fixed Assets Amortisation Charged In Period		138 376
Intangible Fixed Assets Cost Or Valuation		691 882
Share Capital Allotted Called Up Paid	5 000

Company staff

Michael C.

Role: Director

Appointed: 28 April 2014

Latest update: 26 April 2024

People with significant control

Michael C.

Notified on 1 April 2017

Nature of control:

substantial control or influence

Accounts Documents

Account next due date	31 January 2024
Account last made up date	30 April 2022
Confirmation statement next due date	12 May 2024
Confirmation statement last made up date	28 April 2023

Annual Accounts 4 January 2016
Start Date For Period Covered By Report	2014-04-28
End Date For Period Covered By Report	2015-04-30
Date Approval Accounts	4 January 2016
Annual Accounts 24 March 2017
Start Date For Period Covered By Report	2015-05-01
End Date For Period Covered By Report	2016-04-30
Date Approval Accounts	24 March 2017
Annual Accounts
Start Date For Period Covered By Report	2016-05-01
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	01 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts 31 January 2018
End Date For Period Covered By Report	2017-04-30
Date Approval Accounts	31 January 2018

Shard Speciality Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Michael C.

Paul R.

Parveen O.

People with significant control

Michael C.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode